
RESPONSE OF PLASMA PROTHROMBIN TO VITAMIN K SUBSTITUTE THERAPY IN CASES OF HEPATIC DISEASE
J. GARROTT ALLEN, M.D.;
ORMAND C. JULIAN, M.D.
Arch Surg. 1940;41(6):1363-1365.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
Considerable experimental and clinical data now at hand implicate the liver as the site of prothrombin formation.1 Prothrombin deficiency has been reported as occurring in human subjects suffering from damage to the liver even though no biliary obstruction or fistula was present.2 Wilson3 reported that in disease of the liver the degree of hypoprothrombinemia was directly proportional to the amount of hepatic damage as indicated by the hippuric acid test.
The data presented here are concerned with prothrombin studies made on 12 patients with various types of disease of the liver and a lowered level of plasma prothrombin. The initial value for prothrombin, the values after three days, one week and two weeks of treatment and the diagnosis in each case are presented in the table. The prothrombin determinations were made by a modified one stage procedure described elsewhere.4 Each patient received 8 mg. of 2-methyl-1,
. . . [Full Text PDF of this Article]
Author Affiliations
CHICAGO
From the Department of Surgery of the University of Chicago.
Footnotes
This work has been aided by a grant from the Douglas Smith Foundation for Medical Research of the University of Chicago.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|